Open AccessThe Metabolic Syndrome: Where Are We and Where Do We Go?
Author(s) -
Julie Roth,
Sohrab Mobarhan,
Marguerite Clohisy
Publication year - 2002
Publication title -
nutrition reviews
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.958
H-Index - 150
eISSN - 1753-4887
pISSN - 0029-6643
DOI - 10.1301/002966402320583398
Subject(s) - metabolic syndrome , hyperinsulinemia , dyslipidemia , insulin resistance , abdominal obesity , medicine , obesity , endocrinology , bioinformatics , biology
The Metabolic Syndrome, also known as Syndrome X, refers to a constellation of atherosclerotic risk factors, including insulin resistance, hyperinsulinemia, dyslipidemia, essential hypertension, and abdominal obesity. We review four major published studies involving animals and humans that may be linked together in a unified hypothesis and justify a comprehensive approach in the treatment of this ever‐increasing syndrome.